253 related articles for article (PubMed ID: 15897450)
1. Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.
Sum EY; Segara D; Duscio B; Bath ML; Field AS; Sutherland RL; Lindeman GJ; Visvader JE
Proc Natl Acad Sci U S A; 2005 May; 102(21):7659-64. PubMed ID: 15897450
[TBL] [Abstract][Full Text] [Related]
2. The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer.
Visvader JE; Venter D; Hahm K; Santamaria M; Sum EY; O'Reilly L; White D; Williams R; Armes J; Lindeman GJ
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14452-7. PubMed ID: 11734645
[TBL] [Abstract][Full Text] [Related]
3. The LIM-only factor LMO4 regulates expression of the BMP7 gene through an HDAC2-dependent mechanism, and controls cell proliferation and apoptosis of mammary epithelial cells.
Wang N; Lin KK; Lu Z; Lam KS; Newton R; Xu X; Yu Z; Gill GN; Andersen B
Oncogene; 2007 Sep; 26(44):6431-41. PubMed ID: 17452977
[TBL] [Abstract][Full Text] [Related]
4. Loss of the LIM domain protein Lmo4 in the mammary gland during pregnancy impedes lobuloalveolar development.
Sum EY; Shackleton M; Hahm K; Thomas RM; O'Reilly LA; Wagner KU; Lindeman GJ; Visvader JE
Oncogene; 2005 Jul; 24(30):4820-8. PubMed ID: 15856027
[TBL] [Abstract][Full Text] [Related]
5. Expression of an engrailed-LMO4 fusion protein in mammary epithelial cells inhibits mammary gland development in mice.
Wang N; Kudryavtseva E; Ch'en IL; McCormick J; Sugihara TM; Ruiz R; Andersen B
Oncogene; 2004 Feb; 23(8):1507-13. PubMed ID: 14676840
[TBL] [Abstract][Full Text] [Related]
6. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
7. Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland.
Barker HE; Smyth GK; Wettenhall J; Ward TA; Bath ML; Lindeman GJ; Visvader JE
BMC Dev Biol; 2008 Oct; 8():94. PubMed ID: 18826651
[TBL] [Abstract][Full Text] [Related]
8. The LIM domain protein Lmo4 is highly expressed in proliferating mouse epithelial tissues.
Sum EY; O'Reilly LA; Jonas N; Lindeman GJ; Visvader JE
J Histochem Cytochem; 2005 Apr; 53(4):475-86. PubMed ID: 15805422
[TBL] [Abstract][Full Text] [Related]
9. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
[TBL] [Abstract][Full Text] [Related]
10. Repression of Lim only protein 4-activated transcription inhibits proliferation and induces apoptosis of normal mammary epithelial cells and breast cancer cells.
Tian Y; Wang N; Lu Z
Clin Exp Metastasis; 2010 Oct; 27(7):455-63. PubMed ID: 20526802
[TBL] [Abstract][Full Text] [Related]
11. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
12. LMO4 inhibits p53-mediated proliferative inhibition of breast cancer cells through interacting p53.
Zhou X; Sang M; Liu W; Gao W; Xing E; Lü W; Xu Y; Fan X; Jing S; Shan B
Life Sci; 2012 Sep; 91(9-10):358-63. PubMed ID: 22906635
[TBL] [Abstract][Full Text] [Related]
13. LMO4 can interact with Smad proteins and modulate transforming growth factor-beta signaling in epithelial cells.
Lu Z; Lam KS; Wang N; Xu X; Cortes M; Andersen B
Oncogene; 2006 May; 25(20):2920-30. PubMed ID: 16331278
[TBL] [Abstract][Full Text] [Related]
14. LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
Montañez-Wiscovich ME; Seachrist DD; Landis MD; Visvader J; Andersen B; Keri RA
Oncogene; 2009 Oct; 28(41):3608-18. PubMed ID: 19648968
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression.
Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML
Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483
[TBL] [Abstract][Full Text] [Related]
16. Reduction of breast cancer cell migration via up-regulation of TASK-3 two-pore domain K+ channel.
Lee GW; Park HS; Kim EJ; Cho YW; Kim GT; Mun YJ; Choi EJ; Lee JS; Han J; Kang D
Acta Physiol (Oxf); 2012 Apr; 204(4):513-24. PubMed ID: 21910834
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the LMO4 gene, encoding a BRCA1-interacting protein, in breast carcinomas.
Sutherland KD; Visvader JE; Choong DY; Sum EY; Lindeman GJ; Campbell IG
Int J Cancer; 2003 Oct; 107(1):155-8. PubMed ID: 12925972
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
19. A role for CCAAT/enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation.
Zahnow CA; Cardiff RD; Laucirica R; Medina D; Rosen JM
Cancer Res; 2001 Jan; 61(1):261-9. PubMed ID: 11196172
[TBL] [Abstract][Full Text] [Related]
20. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
